ArticleCureus2025
It Is All One-Sided: Monocular Blindness and Charles Bonnet Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Charles Bonnet syndrome in patients referred for cataract surgery.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present the case of a 72-year-old male who developed Charles Bonnet Syndrome (CBS) following a right retinal artery occlusion. Complex visual hallucinations are the main symptom of CBS in persons with substantial vision loss. It has been conventionally associated with bilateral severe impairment, but recent observations indicate under-recognised monocular cases that offer equally notable incidences of CBS. This case highlights the importance of recognising that CBS can also occur in monocular blindness and its underdiagnosed prevalence in current literature. In order to avoid the misidentification of CBS in unilateral vision loss and to empower patients with information and empathy, increased focus on recognising monocular CBS and providing targeted guidance for patients is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.